missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Nicotinamide N-Methyltransferase/NNMT Rabbit anti-Human, Mouse, Rat, Polyclonal, Novus Biologicals™
  7. 18303867

Nicotinamide N-Methyltransferase/NNMT Rabbit anti-Human, Mouse, Rat, Polyclonal, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP3-03406-100UL

 View more versions of this product

Product Code. 18303867

  • £393.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Nicotinamide N-Methyltransferase/NNMT Polyclonal specifically detects Nicotinamide N-Methyltransferase/NNMT in Human, Mouse, Rat samples. It is validated for Western Blot, Immunocytochemistry/Immunofluorescence, Knockout Validated.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Nicotinamide N-Methyltransferase/NNMT
Polyclonal
PBS with 50% glycerol, pH7.3.
Rabbit
Affinity purified
RUO
4837
Store at -20°C. Avoid freeze-thaw cycles.
IgG
Western Blot, Immunofluorescence, KnockDown
Unconjugated
EC 2.1.1.1, nicotinamide N-methyltransferase
Recombinant fusion protein containing a sequence corresponding to amino acids 1-264 of human Nicotinamide N-Methyltransferase/NNMT (NP_006160.1).
100 μL
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.